On May 2024, Qingdao Haier Biomedical Co., Ltd. (688139.SH) announced that the company did not repurchase shares through the Shanghai Stock Exchange trading system by centralized bidding. As of May 31, 2024, the company has repurchased a total of 815,617 shares of the company through the Shanghai Stock Exchange trading system by centralized bidding, accounting for 0.26% of the total share capital of 317,952,508 shares. The highest price paid for the repurchased shares was 32.31 yuan/share, the lowest price was 27.40 yuan/share, and the total amount paid was CNY 25,654,978.48 (excluding transaction fees).
海尔生物(688139.SH)：5月未回购股份
Qingdao Haier Biomedical Co., Ltd. (688139.SH) did not repurchase its shares in May.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.